Medtronic (NYSE: MDT) announced today that it received FDA premarket approval (PMA) for the use of its Infuse bone graft in ...
EDEN PRAIRIE, Minn., March 21, 2025 /PRNewswire/ — To follow up on the completion of its clinical proof-of-concept study, SynerFuse™ and its partner, Velentium Medical, today announced plans to scale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results